Novartis' IFRS net income for 3 months of 2022 was $2.294 billion, up 3.4% from $2.219 billion in the previous year. Revenue increased by 3.4% to $12.953 billion against $12.531 billion a year earlier.
Novartis' IFRS net income for 3 months of 2022 was $2.294 billion, up 3.4% from $2.219 billion in the previous year. Revenue increased by 3.4% to $12.953 billion against $12.531 billion a year earlier. 
novartis.com
English (US) 